• Elevating Translational Immunofluorescence: Cy5-Antibody Inn

  2026-07-30

  This thought-leadership article bridges mechanistic insight and strategic guidance for translational researchers, highlighting how APExBIO's Cy5 Goat Anti-Mouse IgG (H+L) Antibody advances the precision and versatility of immunofluorescence assays. By contextualizing its use within the latest osteogenesis and vaccine research, we illuminate practical workflow strategies and future-facing implications for high-sensitivity detection.

• Tomivosertib Suppresses Human DRG Neuron Hyperactivity in Ra

  2026-07-30

  This study provides the first direct evidence that MNK inhibition by tomivosertib can rapidly and reversibly suppress spontaneous activity in human dorsal root ganglion (DRG) neurons from patients with radiculopathy. The findings establish a mechanistic link between MNK signaling and neuronal hyperexcitability in neuropathic pain, supporting further clinical evaluation of MNK inhibitors for pain management.

• EdU Flow Cytometry Assay Kits (Cy5): DNA Synthesis Detection

  2026-07-29

  EdU Flow Cytometry Assay Kits (Cy5) deliver high-sensitivity, denaturation-free DNA synthesis detection via copper-catalyzed azide-alkyne cycloaddition (CuAAC). The kit enables robust S-phase cell proliferation analysis, supporting reliable benchmarking in research workflows.

• Bsa I (RNase-free): Technical Use and Workflow Parameters

  2026-07-29

  Bsa I (RNase-free) enables precise DNA cleavage for molecular cloning and recombinant DNA workflows requiring minimal RNA degradation. It is not suitable for diagnostic or medical applications and should be strictly used in controlled research environments where RNase-free conditions are essential.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Assay Power

  2026-07-28

  EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) empowers real-time mRNA delivery tracking and robust translation efficiency assessment through its unique Cy5 fluorescence and luciferase bioluminescence dual-reporter system. With advanced chemical modifications enhancing stability and immune evasion, this tool streamlines complex workflows in gene therapy, vaccine research, and intracellular trafficking analysis.

• MRE11:p.K464R Mutation Drives Olaparib Resistance in HGSOC

  2026-07-28

  Zhuang et al. identify the MRE11:p.K464R mutation as a key driver of acquired resistance to olaparib in high-grade serous ovarian cancer (HGSOC) by enhancing DNA damage repair. Their mechanistic insights into non-homologous end joining (NHEJ) highlight new avenues for monitoring and overcoming PARP inhibitor resistance.

• tFUS Reduces Stroke Neuroinflammation via Nespas/miR-383-3p/

  2026-07-27

  This study demonstrates that transcranial focused ultrasound stimulation (tFUS) alleviates NLRP3-mediated neuroinflammation after ischemic stroke by modulating the Nespas/miR-383-3p/SHP2 pathway in microglia. These findings reveal a precise molecular mechanism for tFUS neuroprotection and highlight the SHP2 pathway as a promising target for post-stroke inflammation research.

• Gasdermin C Drives Stemness and Immune Evasion in PDAC

  2026-07-27

  This study reveals that Gasdermin C (GSDMC) promotes stemness and immune evasion in pancreatic ductal adenocarcinoma (PDAC) through a mechanism independent of pyroptosis. By elucidating the nuclear functions of GSDMC and its regulation via ADAM17 cleavage, the research uncovers new therapeutic targets to enhance treatment responses in aggressive pancreatic cancer.

• PDK4-IN-1 Hydrochloride: Rethinking Metabolic Modulation

  2026-07-26

  Explore how PDK4-IN-1 hydrochloride transforms translational research by enabling fine-grained control of mitochondrial energy metabolism. This article bridges mechanistic insight with strategic guidance, referencing pivotal evidence on PDK4 inhibition and setting new standards for experimental design in metabolic, cardiac, and oncology models. Discover actionable parameters, clinical context, and future horizons.

• Obacunone Induces Ferroptosis in Ovarian Cancer via Akt/p53

  2026-07-25

  This study demonstrates that Obacunone, a citrus-derived compound, triggers ferroptosis and suppresses proliferation in ovarian cancer cells by modulating the Akt/p53 pathway. The findings highlight a novel mechanism for targeting chemoresistant tumors and underscore the utility of pathway-specific modulators in dissecting cancer cell death.

• Cy5 amine (non-sulfonated): Technical Guide and Workflow Par

  2026-07-24

  Cy5 amine (non-sulfonated) provides a bright, photostable fluorescent probe for sensitive biomolecule labeling in non-aqueous workflows, such as fluorescence microscopy and flow cytometry. It is unsuitable for direct aqueous labeling or any diagnostic or medical application, requiring careful solvent selection and storage practices.

• (S)-(+)-Ibuprofen: Strategic Advances in Translational COX I

  2026-07-24

  This article provides translational researchers with a deep mechanistic insight into (S)-(+)-Ibuprofen’s selective COX inhibition, strategic guidance for experimental design, and a critical perspective on its evolving role in inflammation research. By connecting state-of-the-art synthesis, experimental rigor, and clinical translation, it outlines how leveraging (S)-(+)-Ibuprofen from APExBIO can accelerate impactful discoveries across the inflammation and pain research landscape.

• Salinomycin in HCC Research: Practical Lab Scenarios & Solut

  2026-07-23

  This article provides a scenario-driven, evidence-based exploration of Salinomycin (SKU A3785) for hepatocellular carcinoma (HCC) research. Leveraging real laboratory challenges, we highlight how Salinomycin’s validated mechanisms, purity, and compatibility—supplied by APExBIO—enable reproducible and sensitive cell-based assays. Researchers will find actionable guidance for experimental design, protocol optimization, and reliable product selection.

• Selective IRAP Inhibitors via α-Hydroxy-β-Amino Acid Bestati

  2026-07-23

  This study introduces a regio- and diastereoselective synthesis of α-hydroxy-β-amino acid derivatives based on bestatin, yielding nanomolar inhibitors with remarkable selectivity for insulin-regulated aminopeptidase (IRAP) over related M1 zinc aminopeptidases. Structural and mechanistic insights advance the chemical toolkit for IRAP-targeted drug design and immunomodulation.

• EPZ5676: Optimized DOT1L Inhibitor Workflows for Leukemia Re

  2026-07-22

  EPZ5676 delivers unprecedented selectivity and nanomolar potency for DOT1L inhibition, making it the gold standard for dissecting H3K79 methylation in MLL-rearranged leukemia models. This guide translates recent mechanistic discoveries and protocol refinements into actionable steps for maximizing experimental success.

649 records 1/44 page Next 12345 下5页 Last page